Immunohistochemical localization of androgen receptor in rat oocytes.

Folia Histochem Cytobiol

Laboratory of Endocrinology and Tissue Culture, Institute of Zoology, Jagiellonian University, Cracow, Poland.

Published: September 2003

Immunohistochemical localization of androgen receptor (AR) was investigated in the rat oocytes during their development in the primary, secondary and antral follicles. The group of experimental Wistar rats included prepubertal female rats, killed at 30 days of age, and mature female rats killed at estrus or metestrus. Excised ovaries were submitted to immunohistochemical procedure in which polyclonal antibody against androgen receptor, avidin-biotin-peroxidase complex, and DAB were used. Characteristic changes in AR immunostaining intensity and localization in the oocyte compartments were observed during the oocyte growth. Relatively strong cytoplasmic AR immunostaining of oocytes from the primordial, primary and some secondary follicles became gradually weaker during the further oocyte development and was only weakly positive in the oocytes from the antral follicles. Germinal vesicles (GVs) usually displayed less intense AR immunostaining than cytoplasm and it was decreasing together with the cytoplasmic depletion of AR. On the contrary, nucleoli appeared as moderately AR-positive structures in the early secondary follicles and were strongly AR-positive in the multilaminar secondary and antral follicles. The presence of AR in the nucleoli persisted even when oocytes had undergone fragmentation in atretic follicles. These findings suggest that during the oocyte growth AR translocates from the oocyte cytoplasm to GV, and then to the nucleolus, which seems to become the main target for this receptor. A possible role of AR in the GV nucleolus is obscure. However, nucleolus contains rRNA genes and is the site of an active transcription, so the role of AR as a ligand-activated, transcriptional factor cannot be excluded.

Download full-text PDF

Source

Publication Analysis

Top Keywords

androgen receptor
12
antral follicles
12
immunohistochemical localization
8
localization androgen
8
rat oocytes
8
primary secondary
8
secondary antral
8
female rats
8
rats killed
8
oocyte growth
8

Similar Publications

Background: We present a systematic review and meta-analysis of randomized clinical trials (RCTs) with PARPi either as monotherapy or in combination with an androgen receptor-targeted agent (ARTA) in first- and second-line settings.

Methods: Primary endpoints are radiographic progression free survival (rPFS) and overall survival (OS) in patients with mCRPC and either unselected, homologous recombination repair wild-type (HRR-), homologous recombination repair mutated (HRR+) or with BRCA1, BRCA2, or ATM mutation. The effect of PARPi + ARTA in the second-line setting is also explored.

View Article and Find Full Text PDF

Minimal study focused on the association between mixed pollutants in atmospheric particulate matter (PM) and their reproductive health risks. Utilizing a novel quantitative structure-activity relationship (QSAR) integrated machine learning algorithms, we evaluated the mixed reproductive health risks associated with phthalates (PAEs) and organophosphates (OPEs) exposure by assessing the affinities of these compounds binding to estrogen receptors (ER) and androgen receptors (AR). The mixed toxicity equivalent factor (TEF) and mixed toxicity equivalent quantity (TEQ) by the QSAR model were all smaller than the sum TEF and TEQ of individual PAEs and OPEs, which may be due to the antagonistic effect of PAEs and OPEs monomers on reproductive toxicity.

View Article and Find Full Text PDF

Among the known nuclear exportins, CRM1 is the most studied prototype. Dysregulation of CRM1 occurs in many cancers, hence, understanding the role of CRM1 in cancer can help in developing synergistic therapeutics. The study investigates how CRM1 affects prostate cancer growth and survival.

View Article and Find Full Text PDF

Gene fusions involving JAZF1 are a recurrent event in low grade endometrial stromal sarcoma, and have been more recently described in few instances of endometrial stromal sarcoma-like tumors in the genitourinary tract of men. In this article, we describe a previously unreported spindle cell sarcoma harboring an in-frame JAZF1::NUDT5 gene fusion, arising in the chest wall of a 51-year-old man. The tumor had unique morphologic features resembling both endometrial stromal sarcoma and endometrial stromal sarcoma-like tumors, consisting of a mixture of cytologically bland and pleomorphic spindle cells with brisk mitotic activity, within an alternating myxoid and fibrous stroma.

View Article and Find Full Text PDF

Lactoferrin conjugated radicicol nanoparticles enhanced drug delivery and cytotoxicity in prostate cancer cells.

Eur J Pharmacol

January 2025

School of Biomedical Sciences, Faculty of Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia; Translational Research Institute, Queensland University of Technology, Brisbane, Australia; Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, Queensland, Australia. Electronic address:

Pyruvate dehydrogenase kinase-1 (PDK1) plays a crucial role in cancer cell metabolism by regulating the glycolytic pathway. Although, inhibitors targeting PDK1 have been effective in inhibiting glycolysis in multiple cancers, their lack of selectivity leading to off-target effects limit their therapeutic benefit. Herein, we investigated the inhibitory potential of six PDK1 inhibitors on cellular proliferation, migration, and invasion of androgen-sensitive LNCaP and androgen-negative PC-3 prostate cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!